GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amdocs (DOX) [hlAlert]

Rating:
Buy DOX
up 83.68 %

Amdocs (DOX) rated Buy with price target $35 by UBS

Posted on: Thursday,  Jul 28, 2011  10:25 AM ET by UBS

UBS rated Buy Amdocs (NASDAQ: DOX) on 07/28/2011, when the stock price was $31.44. Since then,
Amdocs has gained 83.68% as of 01/08/2016's recent price of $57.75.
If you would have followed this UBS's recommendation on DOX, you would have gained 83.68% of your investment in 1625 days.

Amdocs is a leading provider of customer care, billing and order management systems for communications and Internet services. Amdocs has an unparalleled success record in project delivery of its mission-critical products. With human resources of over 5,900 information systems professionals, Amdocs has an installed base of successful projects with more than 75 service providers throughout the world. In April 2000, Amdocs completed the acquisition of Solect Technology Group Inc., a leading provider of customer care and billing systems for IP providers.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/28/2011 10:25 AM Buy
None
31.44 35.00
as of 12/30/2011
1 Week up  0.99 %
1 Month up  1.02 %
3 Months up  5.19 %
1 YTD down  -9.25 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/13/2011 11:25 AM Buy
None
28.16 33.00
1/21/2010 11:25 AM Hold
None
29.95 29.00
1/14/2008 10:50 AM Buy
None
32.92
11/1/2007 11:25 AM Hold
None
34.34 39.00
7/2/2007 10:06 AM Hold
None
39.74 44.00
7/2/2007 10:06 AM Hold
None
39.74 44.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy